1. Home
  2. LQDA vs LION Comparison

LQDA vs LION Comparison

Compare LQDA & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

N/A

Current Price

$47.98

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

N/A

Current Price

$14.26

Market Cap

3.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
LQDA
LION
Founded
2004
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.4B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
LQDA
LION
Price
$47.98
$14.26
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
★ $54.38
$15.33
AVG Volume (30 Days)
★ 3.9M
3.8M
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.81
N/A
EPS
★ 1.26
N/A
Revenue
$158,320,000.00
★ $2,631,800,000.00
Revenue This Year
$357.27
$29.25
Revenue Next Year
$1.34
$1.00
P/E Ratio
$35.40
★ N/A
Revenue Growth
★ 1031.18
N/A
52 Week Low
$22.31
$6.47
52 Week High
$93.61
$16.70

Technical Indicators

Market Signals
Indicator
LQDA
LION
Relative Strength Index (RSI) 55.64 72.52
Support Level $35.00 $13.14
Resistance Level $63.46 $14.78
Average True Range (ATR) 3.10 0.58
MACD 1.61 0.20
Stochastic Oscillator 77.29 95.62

Price Performance

Historical Comparison
LQDA
LION

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: